Vaccine Stock #2: Moderna Moderna, Inc. (MRNA), founded in 2010 and headquartered in Cambridge, Massachusetts, is a biotech pioneer with a $14.2 billion market cap.

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

The Trump Administration said this week it is pulling half a billion dollars from U.S. government-funded research projects to create new mRNA vaccines. Experts say this could potentially impact mRNA ...

During the Covid-19 pandemic, vaccine stocks shot up on the promise that they could end the lockdowns. Many vaccines were developed, but few were approved. Since the end of 2021, even the approved ...

The decision will impact 22 projects speerheaded by major pharmaceutical companies for vaccines against bird flu and other ...

Other vaccine-related companies also felt the fallout. German company BioNTech closed 7% lower, and British GSK fell 2%. US vaccine companies have already been struggling, thanks to lessened demand ...

Surely, it’s not just a coincidence that Novavax stock catapulted higher in mid-May, during the resurgence of meme-stock mania. This wasn’t just a relief rally for COVID-19 vaccine stocks; it ...

Since Trump's election win, several analysts have downgraded their outlooks on vaccine stocks amid the rising uncertainty in the industry. Bank of America analysts lowered their price target on ...

Asia Global stocks mixed amid vaccine, stimulus optimism BEIJING - Global stock markets were mixed Monday amid optimism about government stimulus and the rollout of coronavirus vaccines.